Amgen held its earnings conference call on Wednesday for the first quarter of 2022. The company provided updates on its financial status, clinical trials, revenue and most notably, its ongoing litigation with the Internal Revenue Service.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,